Endocyte Competitors and Similar CompaniesClear all
Endocyte's competitors and similar companies include Cleave Biosciences and TScan Therapeutics.
 Endocyte Endocyte is a biopharmaceutical company that develops receptor-targeted therapeutics to treat cancer and inflammatory diseases. |  Cleave Biosciences Cleave Biosciences is a biopharmaceutical company that discovers and develops therapies for the treatment of cancer. |  TScan Therapeutics TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies. | |
Founding Date | Founding Date 1995 | Founding Date 2010 | Founding Date 2018 |
Type | Type Subsidiary | Type Private | Type Public |
Tags | |||
Locations | Locations West Lafayette, US HQ Saint Genis Pouilly, FR Indianapolis, US | Locations Burlingame, US HQ | Locations Waltham, US HQ |
Employees | Employees 476% decrease | Employees 3 | Employees 7316% increase |
Financial | |||
Revenue (est.) | Revenue (est.) $70k (FY, 2017) | Revenue (est.) N/A | Revenue (est.) $10.3m (FY, 2025) |
Net income | Net income ($55.1m) (FY, 2017) | Net income N/A | Net income ($129.8m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 41m | Total funding raised $ 129m | Total funding raised $ 137.5m |
For sources of this data, please see the company profile
View Company Profiles
Cleave Biosciences
HQ
Burlingame, US
Employees
3
Cleave Biosciences is a biopharmaceutical company that discovers and develops therapies for the treatment of cancer.
View companyTScan Therapeutics
HQ
Waltham, US
Employees
73↑ 16% increase
TScan Therapeutics is a biotechnology company that develops cancer-targeting therapies.
View company